1. Home
  2. INDP vs JVA Comparison

INDP vs JVA Comparison

Compare INDP & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • JVA
  • Stock Information
  • Founded
  • INDP 2000
  • JVA 1971
  • Country
  • INDP United States
  • JVA United States
  • Employees
  • INDP N/A
  • JVA N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • INDP Health Care
  • JVA Consumer Staples
  • Exchange
  • INDP Nasdaq
  • JVA Nasdaq
  • Market Cap
  • INDP 15.4M
  • JVA 14.7M
  • IPO Year
  • INDP N/A
  • JVA 2005
  • Fundamental
  • Price
  • INDP $1.11
  • JVA $2.98
  • Analyst Decision
  • INDP Strong Buy
  • JVA
  • Analyst Count
  • INDP 1
  • JVA 0
  • Target Price
  • INDP $12.00
  • JVA N/A
  • AVG Volume (30 Days)
  • INDP 20.2K
  • JVA 181.9K
  • Earning Date
  • INDP 11-04-2024
  • JVA 10-18-2024
  • Dividend Yield
  • INDP N/A
  • JVA N/A
  • EPS Growth
  • INDP N/A
  • JVA N/A
  • EPS
  • INDP N/A
  • JVA 0.20
  • Revenue
  • INDP N/A
  • JVA $76,111,698.00
  • Revenue This Year
  • INDP N/A
  • JVA N/A
  • Revenue Next Year
  • INDP N/A
  • JVA N/A
  • P/E Ratio
  • INDP N/A
  • JVA $13.96
  • Revenue Growth
  • INDP N/A
  • JVA 17.27
  • 52 Week Low
  • INDP $1.03
  • JVA $0.67
  • 52 Week High
  • INDP $3.25
  • JVA $3.88
  • Technical
  • Relative Strength Index (RSI)
  • INDP 34.05
  • JVA 53.73
  • Support Level
  • INDP $1.10
  • JVA $2.69
  • Resistance Level
  • INDP $1.22
  • JVA $3.12
  • Average True Range (ATR)
  • INDP 0.12
  • JVA 0.26
  • MACD
  • INDP 0.00
  • JVA -0.07
  • Stochastic Oscillator
  • INDP 16.20
  • JVA 27.62

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.

Share on Social Networks: